BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 34537745)

  • 1. INSULIN-LIKE GROWTH FACTORS IN THE SERUM OF PATIENTS WITH PAPILLARY THYROID CANCER.
    Pidchenko NS; Krasnoselskyi MV; Mitriaieva NA; Grebenik LV; Astapieva OM; Grushka GV; Paskevych OI; Fedulenkova YY; Myroshnychenk MS
    Wiad Lek; 2021; 74(8):1925-1930. PubMed ID: 34537745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Papillary Thyroid Carcinoma Recurrence: Low Yield of Neck Ultrasound With an Undetectable Serum Thyroglobulin Level.
    Epstein S; McEachern R; Khot R; Padia S; Patrie JT; Itri JN
    J Ultrasound Med; 2018 Oct; 37(10):2325-2331. PubMed ID: 29498418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of therapeutic doses of 131I in thyroid papillary carcinoma patients with elevated thyroglobulin level and negative 131I whole-body scan: comparative study.
    Koh JM; Kim ES; Ryu JS; Hong SJ; Kim WB; Shong YK
    Clin Endocrinol (Oxf); 2003 Apr; 58(4):421-7. PubMed ID: 12641624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UNFAVORABLE RESPONSES TO RADIOIODINE THERAPY IN N1B PAPILLARY THYROID CANCER: A PROPENSITY SCORE MATCHING STUDY.
    Liu YQ; Li H; Liu JR; Lin YS
    Endocr Pract; 2019 Dec; 25(12):1286-1294. PubMed ID: 31412228
    [No Abstract]   [Full Text] [Related]  

  • 5. Follow-up of differentiated thyroid carcinoma.
    Pagano L; Klain M; Pulcrano M; Angellotti G; Pasano F; Salvatore M; Lombardi G; Biondi B
    Minerva Endocrinol; 2004 Dec; 29(4):161-74. PubMed ID: 15765026
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early postoperative stimulated serum thyroglobulin quantifies risk of recurrence in papillary thyroid cancer.
    Jayasekara J; Jonker P; Lin JF; Engelsman AF; Wong MS; Kruijff S; Aniss A; Learoyd D; Bligh RC; Glover A; Delbridge L; Sidhu S; Sywak M
    Surgery; 2020 Jan; 167(1):40-45. PubMed ID: 31515121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Follow-up of a Toddler with Papillary Thyroid Carcinoma: A Case Report with a Literature Review of Patients Under 5 Years of Age.
    Öztürk AP; Karakılıç Özturan E; Gün Soysal F; Ünal S; Işık G; Yegen G; Önder S; Yıldız M; Poyrazoğlu Ş; Baş F; Darendeliler F
    J Clin Res Pediatr Endocrinol; 2022 Mar; 14(1):119-125. PubMed ID: 33448212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reoperative lymph node dissection for recurrent papillary thyroid cancer and effect on serum thyroglobulin.
    Hughes DT; Laird AM; Miller BS; Gauger PG; Doherty GM
    Ann Surg Oncol; 2012 Sep; 19(9):2951-7. PubMed ID: 22526913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of serial serum thyroglobulin determinations after total thyroidectomy for differentiated thyroid cancer.
    Lima N; Cavaliere H; Tomimori E; Knobel M; Medeiros-Neto G
    J Endocrinol Invest; 2002 Feb; 25(2):110-5. PubMed ID: 11929080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does recombinant human thyrotropin-stimulated positron emission tomography with [18F]fluoro-2-deoxy-D-glucose improve detection of recurrence of well-differentiated thyroid carcinoma in patients with low serum thyroglobulin?
    Vera P; Kuhn-Lansoy C; Edet-Sanson A; Hapdey S; Modzelewski R; Hitzel A; d'Anjou J; Basuyau JP
    Thyroid; 2010 Jan; 20(1):15-23. PubMed ID: 20017617
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
    Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
    J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Post-operative stimulated thyroglobulin and neck ultrasound as personalized criteria for risk stratification and radioactive iodine selection in low- and intermediate-risk papillary thyroid cancer.
    Orlov S; Salari F; Kashat L; Freeman JL; Vescan A; Witterick IJ; Walfish PG
    Endocrine; 2015 Sep; 50(1):130-7. PubMed ID: 25792004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative stimulated thyroglobulin of less than 1 ng/ml as a criterion to spare low-risk patients with papillary thyroid cancer from radioactive iodine ablation.
    Rosario PW; Mineiro Filho AF; Prates BS; Silva LC; Calsolari MR
    Thyroid; 2012 Nov; 22(11):1140-3. PubMed ID: 23050786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Role of Vitamin D, Platelet-Derived Growth Factor and Insulin-Like Growth Factor 1 in the Progression of Thyroid Diseases.
    Abdellateif MS; Shaarawy S; Elesawy YF; Mansour M; Tharwat E; Ibrahim NH; Eissa MS
    Asian Pac J Cancer Prev; 2020 Jul; 21(7):2083-2089. PubMed ID: 32711436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathological evaluation of differentiated thyroid cancer in patients with positive serum thyroglobulin and negative iodine scan.
    Ansari M; Babaei AA; Shafiei B; Javadi H; Assadi M; Nabipour I; Asli IN
    Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1925-9. PubMed ID: 25010624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can patients with papillary thyroid carcinoma and low postoperative thyroglobulin in the presence of clinically apparent lymph node metastases (cN1) be spared from radioiodine?
    Rosario PW; Mourão GF; Calsolari MR
    Endocrine; 2020 Dec; 70(3):552-557. PubMed ID: 32653994
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Papillary thyroid cancer: medical management and follow-up.
    Kloos RT
    Curr Treat Options Oncol; 2005 Jul; 6(4):323-38. PubMed ID: 15967085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of a neck lump as a lymph node metastasis from an occult contralateral papillary microcarcinoma of the thyroid: key role of thyroglobulin assay in the fine-needle aspirate.
    Bruno R; Giannasio P; Chiarella R; Capula C; Russo D; Filetti S; Costante G
    Thyroid; 2009 May; 19(5):531-3. PubMed ID: 19416000
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical meaning of pre- and post-ablation thyroglobulin levels at first radioiodine therapy in patients with papillary thyroid cancer.
    Kim HK; Yoon JH; Cho JS; Kwon SY; Yoo SW; Kang HC
    Korean J Intern Med; 2020 Sep; 35(5):1164-1172. PubMed ID: 31352718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Be Aware of the Patient With Benign Follicular Thyroid Lesion Histology and Rising Thyroglobulin Level.
    Slutzky-Shraga I; Sternov Y; Robenshtock E; Tzvetov G; Benbassat C; Hirsch D
    Endocr Pract; 2018 Aug; 24(8):740-745. PubMed ID: 30106632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.